Chimeric antigen receptor (CAR) T-cell therapies have transformed patient outcomes and treatment approaches for patients with difficult-to-treat hematologic malignancies leading to improved overall survival. However, the use of CAR T-cell therapies is challenging, requiring careful patient selection, prolonged treatment at an authorized treatment center, and ongoing monitoring and support provided by an interprofessional, multidisciplinary care team in the community and treatment center settings. This activity highlights key concepts in managing patients treated with CAR T-cell therapy, provides an overview of the principles of interprofessional collaboration, and describes the importance of close communication and collaboration, particularly during the transition from treatment center back to the community setting.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Address:
- 39000 Bob Hope Drive
Pricing
100% of listed courses are free
31 of 31 courses listed here are free.
Collected from the provider’s public pages
Specialties served/covered
- Cardiovascular Disease
- Critical Care Medicine
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General Pediatrics
- Head & Neck Surgery
- Hematology
- Medical Genetics & Genomics
- Medical Oncology
- Metabolic & Bariatric Surgery
- Neonatal-Perinatal Medicine
- Nephrology
- Neurology
- Obstetrics & Gynecology
- Pediatric Gastroenterology
- Pediatric Hematology-Oncology
- Pediatric Infectious Diseases
- Pediatric Neurology
- Pulmonary Disease
- Transplant Hepatology
- Cardio-Vascular
- Emergency & Critical Care
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Medical Subspecialties
- Neurology
- Ob/Gyn
- Oncology & Hematology
- Pediatrics
- Primary care
- No reviews yet. Be the first to share yours.

